Campobasso Matthew's Form 4 filing
Enfusion, Inc. (ENFN) · filed Mar 7, 2025
- Accession no.
- 0001104659-25-021837
- Filed
- Mar 7, 2025
- Trade date
- Mar 5, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $19.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Campobasso MatthewCIK 0002000984 | Officer (General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 5, 2025 | Class A Common Stock | SSaleDisposed | −1,695 | $11.38F2 | −$19,289.1 | 70,946 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.32 to $11.455. Full information regarding the number of shares sold at each separate price will be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.